Cytomegalovirus in the Pediatric Transplant Recipient: Where Are We Now?
- PMID: 28045876
- PMCID: PMC7228584
- DOI: 10.1097/TP.0000000000001627
Cytomegalovirus in the Pediatric Transplant Recipient: Where Are We Now?
Conflict of interest statement
The authors declare no conflicts of interest.
Comment on
-
Effectiveness of Preemptive Therapy for Cytomegalovirus Disease in Pediatric Liver Transplantation.Transplantation. 2017 Apr;101(4):804-810. doi: 10.1097/TP.0000000000001531. Transplantation. 2017. PMID: 27755504 Free PMC article.
References
-
- Green M, Kaufmann M, Wilson J. Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children Clin Infect Dis 1997. 251344–1349 - PubMed
-
- Razonable RR, Limaye AP. Cytomegalovirus Infection in Solid Organ Transplantation. 4th Edition. Transplant Infections Eds: Ljungman P, Snydman D, Boeckh M. Lippincott-Raven Publishers, Philadelphia PA, Chapter 29. Pp 441–475, 2016.
-
- Razonable RR, Humar A. Cytomegalovirus in solid organ transplantation Am J Transplant 2013. 1393–106 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
